Dr. Philip Brien Dreisbach, MD

Dr. Dreisbach practices at Desert Hematology-Oncology Medical Group Inc in Rancho Mirage, California.

Dr. Dreisbach's NPI, 1972513919, was assigned on August 9, 2006. Dr. Dreisbach graduated from Rutgers New Jersey Medical School in 1969. Dr. Dreisbach's California license number on file is G19293.

Dr. Dreisbach's primary practice is Desert Hematology-Oncology Medical Group Inc, at 34490 Bob Hope Dr, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 568-3613.

Dr. Dreisbach's primary practice is Desert Hematology-Oncology Medical Group Inc in Rancho Mirage, California. Dr. Dreisbach is also affiliated with Eisenhower Health. The medical group on file is Desert Hematology Oncology. Dmand AI also links Dr. Dreisbach to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dreisbach practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dreisbach's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dreisbach is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Dreisbach's licenses on file in 3 states: California, Pennsylvania and Louisiana.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Dreisbach treats.

CMS data shows 127,785 Medicare services from Dr. Dreisbach across 50 procedure codes in 2024, for 675 Medicare patients. Medicare paid $1,689,631 for them.

CMS counts 675 Medicare patients who saw Dr. Dreisbach in 2024. The largest group is 75 to 84, with 293 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dreisbach's median patient age at 72, with 64% women.

In 2024, Dr. Dreisbach wrote 383 Medicare Part D claims for 99 patients. 68% of them were for generic drugs. CMS names the drug for 180 of them, across 10 drugs with 11 or more claims each, at $857,764 in total drug cost. In 2023, CMS named 115 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dreisbach for performance year 2024, reported as part of a group. Dr. Dreisbach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dreisbach as offering telehealth.

CMS Open Payments shows 1,419 general payments to Dr. Dreisbach from 95 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,076.

Dmand AI lists 6 awards for Dr. Dreisbach, most recently CMS Stage 1 EHR in 2014.

Dr. Dreisbach graduated from Rutgers New Jersey Medical School in 1969. Dr. Dreisbach is a member of ASCO.

Dr. Dreisbach is in network with 11 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Aetna. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.